BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Activity

354 hedge funds and large institutions have $8.13B invested in BridgeBio Pharma in 2025 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 135 increasing their positions, 102 reducing their positions, and 33 closing their positions.

Holders
354
Holders Change
+52
Holders Change %
+17.22%
% of All Funds
4.75%
Holding in Top 10
17
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.56%
% of All Funds
0.23%
New
91
Increased
135
Reduced
102
Closed
33
Calls
$388M
Puts
$79.7M
Net Calls
+$308M
Net Calls Change
-$83.4M

Top Buyers

1
FCM
1
Farallon Capital Management
California
$341M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$401M
3
Macquarie Group
3
Macquarie Group
Australia
$90.5M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$89.9M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$712M

Top Sellers

1
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$573M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$801M
3
Citadel Advisors
3
Citadel Advisors
Florida
$14.3M
4
DTC
4
Deep Track Capital
Connecticut
$38.9M
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$15.1M
Name Market Value Shares Shares
Change 		Shares
Change %
DCM
26
Driehaus Capital Management
Illinois
$73M 1,691,213 +190,655 +13%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$72.7M 1,684,055 +1,410,900 +517%
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$70.9M 1,641,620 +841,545 +105%
CAM
29
Cormorant Asset Management
Massachusetts
$69.1M 1,600,000 -400,000 -20%
Lord, Abbett & Co
30
Lord, Abbett & Co
New Jersey
$60.6M 1,403,741 +545,819 +64%
Northern Trust
31
Northern Trust
Illinois
$58.9M 1,363,683 +76,836 +6%
Morgan Stanley
32
Morgan Stanley
New York
$58M 1,342,378 -156,241 -10%
Charles Schwab
33
Charles Schwab
California
$57.5M 1,331,473 +49,244 +4%
Ensign Peak Advisors
34
Ensign Peak Advisors
Utah
$56.8M 1,315,979 -534,060 -29%
Citigroup
35
Citigroup
New York
$53.9M 1,248,505 -153,008 -11%
Bank of America
36
Bank of America
North Carolina
$47.6M 1,101,509 +154,659 +16%
American Century Companies
37
American Century Companies
Missouri
$47.1M 1,090,134 +62,646 +6%
Principal Financial Group
38
Principal Financial Group
Iowa
$44.5M 1,030,527 -117,765 -10%
EA
39
Emerald Advisers
Pennsylvania
$44.1M 1,021,257 -124,234 -11%
SI
40
Sofinnova Investments
California
$42.9M 993,093 +258,866 +35%
PBA
41
Paradigm Biocapital Advisors
New York
$41.7M 965,764 +965,764 New
T. Rowe Price Associates
42
T. Rowe Price Associates
Maryland
$41.5M 961,216 -203,751 -17%
Barclays
43
Barclays
United Kingdom
$40.3M 933,512 +544,674 +140%
CCM
44
Catalio Capital Management
New York
$40.1M 927,711 -35,172 -4%
DTC
45
Deep Track Capital
Connecticut
$38.9M 900,000 -1,900,000 -68%
Franklin Resources
46
Franklin Resources
California
$35.5M 821,405 +482,149 +142%
Ameriprise
47
Ameriprise
Minnesota
$34M 787,044 -254,891 -24%
SPPAM
48
Summit Partners Public Asset Management
Massachusetts
$32.7M 757,745 -371,847 -33%
PAM
49
Panagora Asset Management
Massachusetts
$30.8M 713,491 +97,239 +16%
UBS AM
50
UBS AM
Illinois
$30.4M 704,357 +99,411 +16%
1
2
3 4 5